Outsourcing in Clinical Trials New England 2023
Our this year's Outsourcing in Clinical Trials New England event will boast 4 tracks, meaning there truly is something for everyone;
- Clinical Operations & Outsourcing
- Decentralized & Hybrid Trials
- Rare Disease Trials
- Technology, Innovation & Devices
The programme will, through a variety of interactive session formats, offer insight on promoting successful collaboration between the clinical trials community and once again offer attendees practical take-aways that they can apply to their own studies.
Your chance to meet and catch up with colleagues from across the industry
As this event hear from industry leading speakers, learn what is round the corner in terms of future trends and get the latest knowledge on new and upcoming disruptors.
▶️ Keynote presentations on the topics affecting you
▶️ Join in with audience discussions, panel debates and add your voice to the conversation
Rinaldo Dorman, MBA, CPSMAssociate Director, R&D Global Procurement & Strategic Sourcing
Leigh DallowAdvocate for Rare Disease Research and Development, Treatment Access and Patient Support Educator
As a global leader in business services for over 20 years, TransPerfect is a woman-owned, privately held company with over 90 offices globally on six continents. Since its inception, TransPerfect has been supporting life sciences in the conduct of global clinical development, commercialization and life cycle management of products catering to the health care community.
Advanced Clinical is a global clinical research services organization, providing CRO, FSP, Strategic Resourcing and Consulting Services for biopharmaceutical and medical device organizations. Our company is committed to improving all lives touched by clinical research and we address the hopes of patients and healthcare professionals with industry-leading services and technology in life sciences. Visit our website to learn more about how we deliver a Better Clinical Experience.
Advantage eClinical is an integrated, cloud-based clinical technology platform. Developed by clinicians for clinicians and providing one of the most cost competitive and resource rich options available to sponsors, this cloud platform includes apps for study design, EDC, RTSM, ePRO, safety data and reporting, risk-based monitoring, source data verification, and specimen/shipment tracking. This builds on our long history of clinical trial expertise and leverages existing study designs to empower customers with an expedited set-up.
Founded in 1989, Biotrial is a leading CRO specialized in Early Development with a wide range of services from Non-Clinical Pharmacology, Phase I studies, Phase II-IV Trial Management, Bioanalysis, Oncology, Data Management, Biostatistics, ECG & Imaging Core Lab (QT/QTc Trials, Psychometric Testing, Imaging, EEG/PSG Assessment), Regulatory Affairs to Medical Writing.
With over 40 years’ experience, 600 beds and locations in NA, EU and Asia, Celerion conducts First-in-Human, clinical Proof-of-Concept and patient dose response studies, cardiovascular safety and NDA-enabling clinical pharmacology research. Celerion provides full study services including statistics, data management and biostatistics (including PK/PD analysis), and bioanalytical services.
Deep 6 AI is the leader in precision research software, connecting all research stakeholders in an AI-powered, real-time, data-driven, collaborative ecosystem. Our Precision Matching software mines millions of patient records, including “unstructured” physician notes, to pin-point eligible study patients in real-time. Deep 6 eliminates months of manual data validation, to de-risk and accelerate clinical trials, because clinical trials should be a gatekeeper (accelerator), not a bottleneck to innovation.
Emvenio Research is a leading decentralized research organization (DRO) providing scalable and hybrid decentralized trial solutions improving clinical trial access to underserved and high-risk populations. Our mission is to eliminate the barriers to clinical trials by bringing access to people where they live, work and are willing to engage. Our innovative network of Mobile Research Sites, At Home Visits and Technology Enabled Virtual Visits are a unique blend of global DCT capabilities that can be deployed to better reach, recruit and retain diverse patient populations, while improving their clinical trial experience. We offer global DCT participant-centric approaches that provide flexibility, meet the most challenging clinical trial demands and provide convenience for patients/caregivers in a compliant manner. Emvenio Research is transforming how patients and care-givers engage in and experience clinical research
MedPoint Digital develops intuitive, ICH-GCP compliant eClinical platforms for virtual investigator meetings, trial portals, interactive modules, and virtual clinical trials. Our digital solutions enable sites to be more productive, with online study training, study eBinders (eISF), digital study alerts and SUSARs, patient visit guides, and a wide range of study tools, available via web portals and mobile apps.
Mural Health is a participant management platform that helps manage & streamline the trial experience for patients and caregivers. Using modern payment, transportation, and communication solutions we help drive retention, compliance, and data quality.
Philips BioTel Research is an industry leader in medical imaging and cardiovascular safety testing for clinical trials.
Philips BioTel Research offers global operational support for cardiovascular monitoring in all therapeutic areas, and advances imaging services in oncology, cardiovascular, metabolic, musculoskeletal, neurologic, and medical device studies. Their experienced research team comprises key opinion leaders, board-certified cardiologists and radiologists, sub-specialty scientists, and highly trained technicians – who acquire, evaluate, and report high-quality data through an efficient, cloud-based infrastructure. Many biopharmaceutical trial sponsors rely on or scientific leaders to help design and optimize their protocols and statistical analysis plans. We have conducted clinical trials contributing to the market approval of nearly 100 new drugs to date.